IFF
65
3
OI
52
5
DOW
50
2
LB
21
-43
PG
66
8
O
50
6
NEM
59
-5
BMY
60
4
UAL
79
2
CAT
65
-5
FSLR
43
-3
EQT
40
-22
EXPD
31
2
HCP
62
4
RIG
32
-3
SWKS
51
-4
BF.B
36
-10
CMI
64
-9
RSG
68
3
ZBH
84
13
IFF
65
3
OI
52
5
DOW
50
2
LB
21
-43
PG
66
8
O
50
6
NEM
59
-5
BMY
60
4
UAL
79
2
CAT
65
-5
FSLR
43
-3
EQT
40
-22
EXPD
31
2
HCP
62
4
RIG
32
-3
SWKS
51
-4
BF.B
36
-10
CMI
64
-9
RSG
68
3
ZBH
84
13
Financhill
Back

Arcturus Therapeutics Holdings Stock Predictions

Pulling an Uber in the $500 Billion Smartphone Industry

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
27

ARCT
Arcturus Therapeutics Holdings

Last Price:
$16.41
Seasonality Move:
-0.59%

7 Day Trial

ALL ACCESS PASS

$ 7

Missed investing in Uber? Don't Miss Mode.

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Arcturus Therapeutics Holdings Stock Forecast

  • Over the next 52 weeks, Arcturus Therapeutics Holdings has on average historically risen by 32.3% based on the past 11 years of stock performance.
  • Arcturus Therapeutics Holdings has risen higher in 4 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 36.36%
  • Is Arcturus Therapeutics Holdings Stock Undervalued?
    The current Arcturus Therapeutics Holdings [ARCT] share price is $16.49. The Score for ARCT is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • ARCT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Arcturus Therapeutics Holdings Stock Go Up Next Year?

  • Over the next 52 weeks, Arcturus Therapeutics Holdings has on average historically risen by 32.3% based on the past 11 years of stock performance.

Arcturus Therapeutics Holdings Stock Rating

Sell
27
Arcturus Therapeutics Holdings (ARCT) is a Sell

Is Arcturus Therapeutics Holdings overpriced?

  • Arcturus Therapeutics Holdings has risen higher in 4 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 36.36%

Arcturus Therapeutics Holdings Stock Price History

Is ARCT stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARCT is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
arcturusrx.com

52-Week Data

52-Week High:
45.00
52-Week Low:
14.30

Prediction Charts

Market Cap:
446.7M
Price in USD:
16.49
Volume:
303.1K
Beta:
2.52

Technical Analysis

SMA50:
17.33
SMA100:
18.97
SMA200:
22.76
52-Wk Change:
-48.01%

Stock Predictions

  • Is Arcturus Therapeutics Holdings stock public?
    Yes, Arcturus Therapeutics Holdings is a publicly traded company.
  • What is the Arcturus Therapeutics Holdings stock quote today?
    The Arcturus Therapeutics Holdings stock price is 16.49 USD today.
  • How to buy Arcturus Therapeutics Holdings stock online?
    You can buy Arcturus Therapeutics Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jan-6 18.15 19.07 19.16 17.85
Jan-7 19.28 20.83 21.26 19.26
Jan-8 20.59 18.95 20.94 18.71
Jan-10 18.91 17.98 19.29 17.38
Jan-13 17.73 17.31 17.73 16.19
Jan-14 17.67 16.59 17.67 16.17
Jan-15 17.12 16.76 17.95 16.60
Jan-16 16.67 17.01 17.06 16.07
Jan-17 17.32 16.79 17.51 16.69
Jan-21 16.90 16.41 17.37 16.32
Jan-22 16.40 16.74 17.93 15.92
Jan-23 16.55 17.42 17.55 15.82
Jan-24 17.40 17.12 17.89 16.71
Jan-27 17.12 16.49 17.74 16.26

Arcturus Therapeutics Holdings Earnings

Arcturus Therapeutics Holdings Earnings Report: Per Share Arcturus Therapeutics Holdings Earnings Q1 Q2 Q3 and Q4 last year and next year.

Arcturus Therapeutics Holdings Forecast Revenue Growth

Arcturus Therapeutics Holdings Stock Analysis: Historical quarterly revenues per share for Arcturus Therapeutics Holdings and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.72 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.85 per share, and an increase next year of $2.25 per share.

* Arcturus Therapeutics Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.